Glyceraldehyde-3-Phosphate Dehydrogenases
"Glyceraldehyde-3-Phosphate Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.
| Descriptor ID |
D005987
|
| MeSH Number(s) |
D08.811.682.657.163.750
|
| Concept/Terms |
Glyceraldehyde-3-Phosphate Dehydrogenases- Glyceraldehyde-3-Phosphate Dehydrogenases
- Dehydrogenases, Glyceraldehyde-3-Phosphate
- Triosephosphate Dehydrogenase
- Dehydrogenase, Triosephosphate
- Phosphoglyceraldehyde Dehydrogenase
- Dehydrogenase, Phosphoglyceraldehyde
- GAPD
- Glyceraldehydephosphate Dehydrogenase
- Dehydrogenase, Glyceraldehydephosphate
|
Below are MeSH descriptors whose meaning is more general than "Glyceraldehyde-3-Phosphate Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Glyceraldehyde-3-Phosphate Dehydrogenases".
This graph shows the total number of publications written about "Glyceraldehyde-3-Phosphate Dehydrogenases" by people in this website by year, and whether "Glyceraldehyde-3-Phosphate Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glyceraldehyde-3-Phosphate Dehydrogenases" by people in Profiles.
-
Bhardwaj V, Rizvi N, Lai MB, Lai JC, Bhushan A. Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics. Anticancer Res. 2010 Mar; 30(3):743-9.
-
Agrawal A, Guttapalli A, Narayan S, Albert TJ, Shapiro IM, Risbud MV. Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. Am J Physiol Cell Physiol. 2007 Aug; 293(2):C621-31.
-
He Y, Macarak EJ, Korostoff JM, Howard PS. Compression and tension: differential effects on matrix accumulation by periodontal ligament fibroblasts in vitro. Connect Tissue Res. 2004; 45(1):28-39.
-
Christiansen M, Kveiborg M, Kassem M, Clark BF, Rattan SI. CBFA1 and topoisomerase I mRNA levels decline during cellular aging of human trabecular osteoblasts. J Gerontol A Biol Sci Med Sci. 2000 Apr; 55(4):B194-200.
-
Amemiya K, Semino-Mora C, Granger RP, Dalakas MC. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol. 2000 Feb; 94(2):99-104.
-
Koshy B, Matilla T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet. 1996 Sep; 5(9):1311-8.
-
Gr?ssel S, Cohen IR, Murdoch AD, Eichstetter I, Iozzo RV. The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester. Mol Cell Biochem. 1995 Apr 12; 145(1):61-8.